Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01560273 · ClinicalTrials.gov registry record
Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 25
- Enrollment target
NCT01560273: Clinical Trial study, sponsored by Zimmer Biomet.
NCT01560273 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01560273 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate the clinical outcomes of subject with spondylolisthesis undergoing posterolateral fusion (PLF) surgery utilizing the Aspen™ Spinous Process Fixation System. The Aspen™ device will be evaluated using Oswestry Disability Index (ODI) improvement and success of fusion.
Interventions
- DEVICE Aspen Spinous Process Fixation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-02 |
| Est. Completion | 2015-09 |
Why NCT01560273 stopped before completion
NCT01560273 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Aspen Spinous Process Fixation Device is the first listed.
NCT01560273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01560273 about?
NCT01560273 is a clinical study titled "Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis". The purpose of this clinical investigation is to evaluate the clinical outcomes of subject with spondylolisthesis undergoing posterolateral fusion (PLF) surgery utilizing the Aspen™ Spinous Process Fixation System. The Aspen™ device will be evaluated using Oswestry Disability Index (ODI) improvement...
What is the current status of trial NCT01560273?
This trial is currently terminated. The enrollment target is 25 participants. The study started on 2012-02. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01560273?
The interventions under investigation include: Aspen Spinous Process Fixation Device (DEVICE).
Who is sponsoring clinical trial NCT01560273?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia